Research analysts at StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a research note issued to investors on Monday. The firm set a “sell” rating on the stock.
Ampio Pharmaceuticals Price Performance
Shares of AMPE opened at $0.13 on Monday. The business’s fifty day moving average price is $0.24 and its 200 day moving average price is $1.17. Ampio Pharmaceuticals has a 12-month low of $0.13 and a 12-month high of $8.30. The stock has a market capitalization of $148,200.00, a PE ratio of -0.01 and a beta of 2.15.
Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) last announced its quarterly earnings data on Wednesday, March 27th. The company reported ($2.48) earnings per share (EPS) for the quarter.
About Ampio Pharmaceuticals
Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.
Featured Stories
- Five stocks we like better than Ampio Pharmaceuticals
- There Are Different Types of Stock To Invest In
- Micron Technology Stock Volatile Despite Analyst Upgrades
- Profitably Trade Stocks at 52-Week Highs
- McDonald’s Stock: Balancing Value and Innovation
- How is Compound Interest Calculated?
- MarketBeat Week in Review – 6/17 – 6/21
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
